Pfizer Wants FDA Emergency Approval For COVID Treatment
Pfizer Inc. said Tuesday it's seeking emergency use authorization from the U.S. Food and Drug Administration for Paxlovid, its experimental antiviral treatment for COVID-19, the same day it announced a licensing...To view the full article, register now.
Already a subscriber? Click here to view full article